Michelle Achor, DPM
Podiatrist · Troy, OHNPI 1669646568
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Paragon 28, Inc. at 40.0% of the total. Reporting peaked in 2021 at $3,022 and has fallen 98.2% since, to $54 in 2025.
Across 45 payments — averaging $166.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$3K
- Stryker$3K
- CDC Medical LLC$1K
- Smith+Nephew$97
- Treace Medical Concepts, Inc.$45
- Dynasplint Systems Inc.$41
- plus $125 from 6 others
What the payments were for
- Travel & lodging$4,37958%
- Food & beverage$1,89325%
- Education$1,22516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 8 | $2,998 |
| Stryker | 21 | $2,901 |
| CDC Medical LLC | 2 | $1,289 |
| Smith+Nephew | 4 | $97 |
| Treace Medical Concepts, Inc. | 1 | $45 |
| Dynasplint Systems Inc. | 1 | $41 |
| Organogenesis Inc. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Legacy Ortho LLC | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $16 |
| Bioventus LLC | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$2,032
- ORTHOLOC 3DI$1,679
- Lapidus$874
- ORTHOLOC 2 LAPIFUSE$677
- Viaflow$219
- FLEXBAND$121
- ALLOPURE$121
- ALLOFIBER$121
- PROSTEP MICA$115
- AUGMENT INJECTABLE$115
- DART-FIRE$104
How this compares
$7,497 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 64 | $1,286 |
| Ketoconazole | 52 | $707 |
| Gabapentin | 93 | $675 |
| Ciclopirox | 30 | $596 |
| Nystatin | 65 | $556 |
| Cephalexin | 32 | $431 |
| Doxycycline Monohydrate | 42 | $420 |
| Econazole Nitrate | 40 | $413 |
| Pregabalin | 21 | $249 |
| Ammonium Lactate | 27 | $248 |
| Mupirocin | 41 | $244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $74 |
| Meloxicam | 27 | $64 |
| Methylprednisolone | 13 | $59 |
| Ondansetron OdtOndansetron | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Troy
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Eric StortsLondon$101K
- Daniel LoganGahanna$83K
- Howard KimmelBrookpark$67K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.